2018
DOI: 10.1021/acs.joc.7b03268
|View full text |Cite
|
Sign up to set email alerts
|

Total Synthesis of Clavilactones

Abstract: Clavilactones A, B, and D are epidermal growth factor receptor tyrosine kinase inhibitors that were isolated from cultures of the fungus Clitocybe clavipes. Here, we report full details of the total synthesis of these clavilactones. A key feature of our synthetic approach is a ring-opening/ring-closing metathesis strategy that allows the concise transformation of a cyclobutenecarboxylate into a γ-butenolide. Coupled with enantioselective Ti/BINOL-catalyzed alkynylation of a multisubstituted benzaldehyde and ri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 47 publications
0
10
0
Order By: Relevance
“…251 The total synthesis process of the EGFR tyrosine kinase inhibitors, 244 , 245 , and 247 , as well as the revision of the structure of 247 , was reported by the Takao group. 252 Another new meroterpenoid analog, clavilactone F ( 249 ), was isolated from C. clavipes in 2019 by Sun et al , along with 244 and 247 . 253 They were evaluated for antiproliferative activities against human cancer cells HepG2 and A549, as well as against normal cell line GES-1; however, they did not show any significant activity ( 249 : IC 50 = 18.22–33.27 μM, 244 : IC 50 = 32.14 μM against HepG2, IC 50 >50 μM and >100 μM against A549 and GES-1, respectively, and 247 : IC 50 = 9.32 μM–38.13 μM).…”
Section: Non-peptide Secondary Metabolites From Poisonous Mushroomsmentioning
confidence: 99%
“…251 The total synthesis process of the EGFR tyrosine kinase inhibitors, 244 , 245 , and 247 , as well as the revision of the structure of 247 , was reported by the Takao group. 252 Another new meroterpenoid analog, clavilactone F ( 249 ), was isolated from C. clavipes in 2019 by Sun et al , along with 244 and 247 . 253 They were evaluated for antiproliferative activities against human cancer cells HepG2 and A549, as well as against normal cell line GES-1; however, they did not show any significant activity ( 249 : IC 50 = 18.22–33.27 μM, 244 : IC 50 = 32.14 μM against HepG2, IC 50 >50 μM and >100 μM against A549 and GES-1, respectively, and 247 : IC 50 = 9.32 μM–38.13 μM).…”
Section: Non-peptide Secondary Metabolites From Poisonous Mushroomsmentioning
confidence: 99%
“…The structures of clavilactones D and E (7), were initially inferred by 1-and 2-D NMR data [67]. However, the subsequent total synthesis of clavilactones A, B, and D led to a revision of the original structure of clavilactone D which was established to be as formula (8) in Figure 4 [68]. Clavilactone A, B, and D displayed potent inhibitory activity in kinase assays against the Ret/ptc1 and epidermal growth factor receptor (EGFR) tyrosine kinases [67,69].…”
Section: Ampulloclitocybe Clavipes (Pers) Redhead Lutzoni Moncalvomentioning
confidence: 99%
“…[6c] In at otal synthesis of clavilactone A, Takao and coworkers strategically exploited ethylene to retrieve aproduct from its homocoupled state (Scheme 3). [7] Zhenxing Liu was born in Dengzhou, China. He received his undergraduate degree at Zhengzhou University in 2011.…”
Section: Fori Mproving Efficiencymentioning
confidence: 99%